Cannell & Spears’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Sell
14,720
-12,000
-45% -$1.63M 0.04% 186
2025
Q4
$3.04M Buy
26,720
+910
+4% +$111K 0.06% 166
2025
Q3
$3.43M Sell
25,810
-11
-0% -$1.51K 0.06% 162
2025
Q2
$3.68M Sell
25,821
-74
-0.3% -$10.5K 0.07% 160
2025
Q1
$3.96M Sell
25,895
-575
-2% -$90.3K 0.09% 147
2024
Q4
$3.96M Sell
26,470
-810
-3% -$127K 0.08% 145
2024
Q3
$4.47M Buy
27,280
+1,000
+4% +$148K 0.09% 138
2024
Q2
$3.64M Hold
26,280
0.08% 141
2024
Q1
$3.63M Buy
+26,280
New +$3.15M 0.08% 142

Other funds holding DVA

Cannell & Spears's DVA Position: Q1 2026 in Review

Cannell & Spears reduced its DaVita (DVA) stake by 45% in Q1 2026, selling an estimated $1.63M and leaving 14,720 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #186.

Cannell & Spears first reported a position in DVA in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.47M in Q3 2024. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • Cannell & Spears held 14,720 shares of DaVita worth $2.26M as of Q1 2026.
  • Cannell & Spears sold 12,000 DaVita shares in Q1 2026, an estimated $1.63M.
  • DaVita made up 0.04% of Cannell & Spears's portfolio in Q1 2026, its #186 holding.
  • Cannell & Spears first reported a position in DaVita in Q1 2024 and has held it in 9 quarters since.
  • Cannell & Spears's DaVita position peaked at $4.47M in Q3 2024.
  • 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.